Moneco Advisors, LLC Spring Works Therapeutics, Inc. Transaction History
Moneco Advisors, LLC
- $912 Million
- Q4 2024
A detailed history of Moneco Advisors, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Moneco Advisors, LLC holds 17,852 shares of SWTX stock, worth $953,475. This represents 0.07% of its overall portfolio holdings.
Number of Shares
17,852
Previous 17,852
-0.0%
Holding current value
$953,475
Previous $571,000
12.78%
% of portfolio
0.07%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$382 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$300 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$185 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$175 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$160 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.33B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...